24 June 2021 – PARIS, France
Here are five companies in the private medtech sector that have caught our eye this year. For more private medtech companies to keep an eye on, be sure to check out The Ultimate List of Private Medtech Companies to Watch, which we updated in May.
Cagent Vascular
Wayne, PA-based Cagent Vascular is developing next-generation angioplasty balloons using serration technology. The company’s Serranator PTA Serration Balloon Catheter is an angioplasty device with serrated metal strips embedded on a semi-compliant balloon. The Serranator is designed to create multiple longitudinal lines of interrupted micro-serrations within the luminal surface to aid in arterial expansion. The result is predictable and controlled lumen gain using low atmospheres of pressure, the company said.
Cagent recently received a $9 million investment from Sectoral Asset Management to accelerate the commercialization and scaling of manufacturing for the Serranator below-the-knee (BTK) product. Further uses of proceeds include expanding the product offering to include larger sizes to treat the above-the-knee arteries.
“Our BTK product launch is going extremely well. Early commercial adoption and clinical outcomes are confirming the positive results seen in the PRELUDE-BTK study. We are delighted to have a high-quality investor like Sectoral join our team. Their deep experience investing and advising device companies focused on peripheral vascular interventions will enable a more rapid expansion of our commercial efforts,” said CEO Carol A. Burns.
Source: MDDI